S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

Clinical trial NCT01809691 · COMPLETED

Trial details

NCT number: NCT01809691
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2013-03-08
Primary completion: 2022-03-08
Enrollment: 1313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.